Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1982;65:899-904

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ames, R. P.
Right arrow Articles by Hill, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ames, R. P.
Right arrow Articles by Hill, P.

Circulation, Vol 65, 899-904, Copyright © 1982 by American Heart Association


ARTICLES

Improvement of glucose tolerance and lowering of glycohemoglobin and serum lipid concentrations after discontinuation of antihypertensive drug therapy

RP Ames and P Hill

Diuretic-based antihypertensive drug therapy causes a disturbance in glucose tolerance and in serum lipid and lipoprotein concentrations. To determine the reversibility of the glucose intolerance and to identify mechanisms of the metabolic alterations, we examined a short glucose tolerance test and insulin, glycohemoglobin and lipid concentrations during the supervised withdrawal of long-term drug therapy in 35 patients with primary hypertension. An average of 7 weeks after stopping drugs, glucose tolerance and glycohemoglobin improved, total cholesterol decreased 18 mg/dl, triglyceride decreased 27 mg/dl, and the ratio of total to high-density lipoprotein cholesterol decreased (p less than 0.01 for all variables vs treatment values). The changes in lipid concentrations from the treated to untreated state correlated with the changes in glycohemoglobin and indexes of glucose metabolism. The findings suggest that insulin resistance develops during drug therapy and disturbs both glucose and lipid metabolism. Attention to these alterations may provide directions for further control of atherosclerotic complications during the treatment of hypertension.


This article has been cited by other articles:


Home page
Journal of Pharmacy PracticeHome page
M. E. Carasiti
Diuretics--Current Issues and Updates
Journal of Pharmacy Practice, January 1, 1990; 3(5): 295 - 304.
[PDF]


Home page
Arch Intern MedHome page
K. Osei, G. Holland, and J. M. Falko
Indapamide: Effects on Apoprotein, Lipoprotein, and Glucoregulation in Ambulatory Diabetic Patients
Arch Intern Med, October 1, 1986; 146(10): 1973 - 1977.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
N. M. Kaplan
Mild Hypertension: When and How to Treat
Arch Intern Med, February 1, 1983; 143(2): 255 - 259.
[Abstract] [PDF]